C.S. Kwon
- Clinical Biochemistry top 5%
- Nephrology top 10%
- Chronic Kidney Disease and Diabetes 2
- Renal Diseases and Glomerulopathies 2
-
- Platelet Disorders and Treatments 5
- Acute Myeloid Leukemia Research 2
-
- Chronic Lymphocytic Leukemia Research 4
-
- Diabetes Treatment and Management 3
-
- Bladder and Urothelial Cancer Treatments 2
- Urinary and Genital Oncology Studies 2
- Co-authors
- Peter M. FarrellAnna ForsythePatrick DanieleChristopher NgaiElizabeth T. MastersRosa Rodríguez-MonguióEnrique Seoane‐VazquezCarla Mamolo
- Journals
- Value in Health (4 papers)ClinicoEconomics and Outcomes Research (2 papers)Blood (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
C.S. Kwon
19 papers receiving 346 citations
Peers
Comparison fields: 5 of 70
- Clinical Biochemistry 72
- Nephrology 55
- Hematology 59
- Urology 23
- Pediatrics, Perinatology and Child Health 57
Countries citing papers authored by C.S. Kwon
This map shows the geographic impact of C.S. Kwon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.S. Kwon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.S. Kwon more than expected).
Fields of papers citing papers by C.S. Kwon
This network shows the impact of papers produced by C.S. Kwon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.S. Kwon. The network helps show where C.S. Kwon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C.S. Kwon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 37 | |
| 4 | Treatment Outcomes of High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) in Real-World Evidence (RWE) Studies: Systematic Literature Review (SLR) | 2022 | 20 |
| 5 | 2021 | 29 | |
| 6 | 2021 | 30 | |
| 7 | 2020 | 32 | |
| 8 | 2020 | 9 | |
| 9 | 2019 | 13 | |
| 10 | 2018 | 22 | |
| 11 | 2018 | 2 | |
| 12 | 2017 | 0 | |
| 13 | 2017 | 1 | |
| 14 | 2017 | 3 | |
| 15 | 2017 | 4 | |
| 16 | 2017 | 1 | |
| 17 | 2016 | 0 | |
| 18 | Screening of Thrombin Inhibitors from Medicinal and Wild Plants | 2005 | 5 |
| 19 | 2005 | 3 | |
| 20 | 2000 | 122 |
About C.S. Kwon
C.S. Kwon is a scholar working on Hematology, Genetics and Urology, having authored 21 papers that have together received 360 indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Diabetes Treatment and Management (3 papers), Acute Myeloid Leukemia Research (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Chronic Kidney Disease and Diabetes (2 papers), Renal Diseases and Glomerulopathies (2 papers) and Urinary and Genital Oncology Studies (2 papers). The work is most often cited by research in Clinical Biochemistry (72 citations), Nephrology (55 citations) and Hematology (59 citations). C.S. Kwon has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Peter M. Farrell, Anna Forsythe, Patrick Daniele, Christopher Ngai, Elizabeth T. Masters, Rosa Rodríguez-Monguió, Enrique Seoane‐Vazquez, Carla Mamolo, Ira Jacobs and Lauren J. Lee. Their work appears in journals such as Value in Health, ClinicoEconomics and Outcomes Research, Blood, Epilepsy & Behavior and BMC Health Services Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.